Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Di Liberato

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 17, 2021
[Psychological evaluation of patient on chronic dialysis treatment: comparison between home and hospital replacement techniques]Francesca Manari, Lorenzo Di Liberato, Mario Bonomini
Kidney Medicine|July 7, 2023
Treatment Options for Anemia in Kidney Transplant Patients: A ReviewMario Bonomini, Lorenzo Di Liberato, Vittorio Sirolli
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 7, 2024
[Survey and Intervention Tools for Burnout in Dialysis Healthcare Staff]Francesca Manari, Lorenzo Di Liberato, Mario Bonomini
Biomedicines|April 23, 2022
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis TherapyMario Bonomini, Luca Piscitani, Lorenzo Di Liberato, et al.
Molecules (Basel, Switzerland)|September 25, 2019
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal DialysisMario Bonomini, Lorenzo Di Liberato, Victor Zammit, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 3, 2011
[L-carnitine in peritoneal dialysis]Amedeo Franco De Vecchi, Arduino Arduini, Lorenzo Di Liberato, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist]Danilo D'Ettorre, Lorenzo Di Liberato, Vittorio Sirolli, et al.
International Journal of Molecular Sciences|July 16, 2020
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological ConsiderationsLuca Piscitani, Vittorio Sirolli, Lorenzo Di Liberato, et al.
International Medical Case Reports Journal|June 11, 2021
IgA Deficiency and Membranoproliferative Glomerulonephritis: A Case ReportAlessandro Pezzutto, Vittorio Sirolli, Lorenzo Di Liberato, et al.
Journal of Nephrology|January 30, 2024
Successful wound healing by autologous peripheral blood mononuclear cell therapy in a diabetic patient on hemodialysis with no-option critical limb ischemia: a case reportMartina Capone, Raffaele Trulli, Olsi Ndrecka, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 17, 2021
[Psychological evaluation of patient on chronic dialysis treatment: comparison between home and hospital replacement techniques]Francesca Manari, Lorenzo Di Liberato, Mario Bonomini
Kidney Medicine|July 7, 2023
Treatment Options for Anemia in Kidney Transplant Patients: A ReviewMario Bonomini, Lorenzo Di Liberato, Vittorio Sirolli
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 7, 2024
[Survey and Intervention Tools for Burnout in Dialysis Healthcare Staff]Francesca Manari, Lorenzo Di Liberato, Mario Bonomini
Biomedicines|April 23, 2022
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis TherapyMario Bonomini, Luca Piscitani, Lorenzo Di Liberato, et al.
Molecules (Basel, Switzerland)|September 25, 2019
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal DialysisMario Bonomini, Lorenzo Di Liberato, Victor Zammit, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 3, 2011
[L-carnitine in peritoneal dialysis]Amedeo Franco De Vecchi, Arduino Arduini, Lorenzo Di Liberato, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist]Danilo D'Ettorre, Lorenzo Di Liberato, Vittorio Sirolli, et al.
International Journal of Molecular Sciences|July 16, 2020
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological ConsiderationsLuca Piscitani, Vittorio Sirolli, Lorenzo Di Liberato, et al.
International Medical Case Reports Journal|June 11, 2021
IgA Deficiency and Membranoproliferative Glomerulonephritis: A Case ReportAlessandro Pezzutto, Vittorio Sirolli, Lorenzo Di Liberato, et al.
Journal of Nephrology|January 30, 2024
Successful wound healing by autologous peripheral blood mononuclear cell therapy in a diabetic patient on hemodialysis with no-option critical limb ischemia: a case reportMartina Capone, Raffaele Trulli, Olsi Ndrecka, et al.
Pageof 4